Investigating how a specific mutation affects brain cancer treatment and immune response.
Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.
This study is looking at a tough type of brain cancer in kids and how a specific gene change affects the way the body fights the tumor and responds to treatment, hoping to find better ways to help kids with this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11005048 on NIH RePORTER |
What this research studies
This research focuses on pediatric high-grade gliomas (pHGG), a severe form of brain cancer, and examines the impact of the H3.3-G343R mutation on the DNA damage response and anti-tumor immunity. By utilizing genetically engineered mouse models that mimic the human immune system, the study aims to understand how this mutation influences tumor behavior and the surrounding immune environment. The researchers will analyze the molecular pathways involved in tumor growth and resistance to treatment, providing insights that could lead to improved therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with pediatric high-grade gliomas, particularly those with the H3.3-G343R mutation.
Not a fit: Patients with other types of brain tumors or those without the specific H3.3-G343R mutation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pediatric brain cancer, potentially improving survival rates and quality of life for affected children.
How similar studies have performed: Previous research has shown promising results in understanding tumor biology and immune interactions in similar models, indicating potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Castro, Maria G — University of Michigan at Ann Arbor
- Study coordinator: Castro, Maria G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.